Pharmacist Tarek El-Ansary, LDN Radio Show 10 July 2019 (LDN, low dose naltrexone)

Pharmacist Tarek El-Ansary, LDN Radio Show 10 July 2019 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Linda Elsegood: My guest is Tarek El-Ansary. He’s the owner of Carmel Valley Pharmacy. He’s also a doctor of pharmacy. Thank you for joining us today. Tarik  Dr Tarek El-Ansary: yes, my pleasure. Thank you for […]

Paul Battle PA-C, LDN Radio Show 22 Feb 2017 (LDN, low dose naltrexone)

Paul Battle PA-C, LDN Radio Show 22 Feb 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Linda Elsegood: today. Our guest is physician assistant Paul Battle from Colorado. Paul is an experienced LDN prescriber and also has personal experience of LDN. Paul Battle PA-C: Thank you. I really appreciate it. Linda Elsegood: Well, […]

Dr Steven Richeimer, LDN Radio Show (LDN, low dose naltrexone)

Dr Steven Richeimer, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Dr Steven Richeimer shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood. Dr Steven Richeimer primarily uses Low Dose Naltrexone (LDN) for neuropathic pain diagnosis, including fibromyalgia which closely relates to complex regional […]

Dr Samyadev Datta, LDN Radio Show (LDN, low dose naltrexone)

Dr Samyadev Datta, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Dr Samyadev Datta shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood. Dr Samyadev Datta was first introduced to Low Dose Naltrexone (LDN) in 2012 by Dr Pradeep Chopra, who explained the myriad […]

Immunometabolic Modulatory Role of Naltrexone in BV-2 Microglia Cells (Abstract)

Immunometabolic Modulatory Role of Naltrexone in BV-2 Microglia Cells Int J Mol Sci 05 Aug 2021 https://pubmed.ncbi.nlm.nih.gov/34445130/ Background: Naltrexone is an opioid receptor antagonist commonly used to treat opioid and alcohol dependence. The use of low dose naltrexone (LDN) was found to have anti-inflammatory properties for treatment of diseases such as fibromyalgia, Crohn’s disease, multiple […]

Dr Richard Nahas, LDN Radio Show 12 April 2017 (LDN, low dose naltrexone)

Dr Richard Nahas, LDN Radio Show 12 April 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Dr Richard Nahas shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood. Dr Richard Nahas is an LDN prescriber from Ottawa in Canada specialising in Brain Function and Brain Health.Dr […]

Dr Kat Toups, LDN Radio Show 15 March 2017 (LDN, low dose naltrexone)

Dr Kat Toups, LDN Radio Show 15 March 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Dr. Kat Toups is an MD from California in the US,  a functional medicine doctor and a psychiatrist. After graduating, being a psychiatrist I ending up working in a research centre, found trials and studies on […]

Dr John Kim, LDN Radio Show 07 Dec 2016 (LDN, low dose naltrexone)

Dr John Kim, LDN Radio Show 07 Dec 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Linda Elsegood: Today we’re joined by Dr John Kim. Thank you for joining us, John. Dr John Kim: Well, thank you for the invitation, Linda, Linda Elsegood: For those people that haven’t heard you on our […]

Complex Regional Pain Syndrome: A Comprehensive Review (Abstract)

Complex Regional Pain Syndrome: A Comprehensive Review  Pain Ther 24 June 2021 https://pubmed.ncbi.nlm.nih.gov/34165690/ Complex regional pain syndrome (CRPS) is a chronic pain condition often involving hyperalgesia and allodynia of the extremities. CRPS is divided into CRPS-I and CRPS-II. Type I occurs when there is no confirmed nerve injury. Type II is when there is known […]

Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome… (Abstract)

Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review Pain Physician July 2021 https://pubmed.ncbi.nlm.nih.gov/34213865/ Background: Complex regional pain syndrome is a rare, neuropathic disorder that affects fewer than 200,000 individuals in the United States annually. Current treatments often focus on pain management and fall short of relieving symptoms of pain […]